This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss.
Diabetes, obesity & metabolism, 24(1), 94-105
Citation
Wharton, Sean; Calanna, Salvatore; Davies, Melanie; Dicker, Dror; Goldman, Bryan; Lingvay, Ildiko; Mosenzon, Ofri; Rubino, Domenica M; Thomsen, Mette; Wadden, Thomas A; Pedersen, Sue D. (2022). Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss.. Diabetes, obesity & metabolism, 24(1), 94-105. https://doi.org/10.1111/dom.14551